HCA Healthcare (NYSE:HCA) Downgraded to “Buy” at StockNews.com

StockNews.com cut shares of HCA Healthcare (NYSE:HCAGet Rating) from a strong-buy rating to a buy rating in a report issued on Thursday morning.

Several other analysts have also recently issued reports on the company. BMO Capital Markets cut HCA Healthcare from a market perform rating to an underperform rating and cut their target price for the stock from $233.00 to $160.00 in a research report on Wednesday, July 6th. Raymond James increased their target price on HCA Healthcare from $230.00 to $250.00 and gave the stock an outperform rating in a research report on Friday, September 16th. Citigroup cut their price target on HCA Healthcare from $254.00 to $240.00 in a report on Tuesday, July 26th. Stephens raised their price target on HCA Healthcare to $230.00 in a report on Monday, July 25th. Finally, Oppenheimer set a $255.00 price target on HCA Healthcare in a report on Monday, June 20th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare presently has an average rating of Moderate Buy and an average target price of $239.14.

HCA Healthcare Stock Performance

Shares of HCA opened at $194.06 on Thursday. The company has a quick ratio of 1.32, a current ratio of 1.55 and a debt-to-equity ratio of 87.46. The business has a 50-day simple moving average of $205.76 and a two-hundred day simple moving average of $214.90. The stock has a market cap of $55.70 billion, a price-to-earnings ratio of 9.33, a PEG ratio of 1.53 and a beta of 1.72. HCA Healthcare has a 52 week low of $164.47 and a 52 week high of $279.02.

HCA Healthcare (NYSE:HCAGet Rating) last issued its quarterly earnings results on Friday, July 22nd. The company reported $4.21 EPS for the quarter, topping analysts’ consensus estimates of $3.67 by $0.54. HCA Healthcare had a return on equity of 833.68% and a net margin of 10.83%. The business had revenue of $14.82 billion during the quarter, compared to analysts’ expectations of $14.73 billion. During the same quarter in the prior year, the business posted $4.37 earnings per share. The business’s quarterly revenue was up 2.7% on a year-over-year basis. On average, analysts expect that HCA Healthcare will post 17.09 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 30th. Investors of record on Friday, September 16th will be paid a dividend of $0.56 per share. This represents a $2.24 dividend on an annualized basis and a dividend yield of 1.15%. The ex-dividend date of this dividend is Thursday, September 15th. HCA Healthcare’s dividend payout ratio is currently 10.77%.

Insider Buying and Selling

In other news, major shareholder Patricia F. Elcan bought 325 shares of the firm’s stock in a transaction on Monday, July 25th. The stock was acquired at an average cost of $198.66 per share, with a total value of $64,564.50. Following the transaction, the insider now directly owns 89,337 shares in the company, valued at approximately $17,747,688.42. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in HCA. Ellevest Inc. raised its stake in shares of HCA Healthcare by 33.6% in the first quarter. Ellevest Inc. now owns 187 shares of the company’s stock valued at $47,000 after acquiring an additional 47 shares in the last quarter. Brown Brothers Harriman & Co. raised its stake in shares of HCA Healthcare by 12.8% in the second quarter. Brown Brothers Harriman & Co. now owns 413 shares of the company’s stock valued at $69,000 after acquiring an additional 47 shares in the last quarter. Veriti Management LLC raised its stake in shares of HCA Healthcare by 4.0% in the first quarter. Veriti Management LLC now owns 1,297 shares of the company’s stock valued at $325,000 after acquiring an additional 50 shares in the last quarter. Oliver Luxxe Assets LLC raised its stake in shares of HCA Healthcare by 0.4% in the fourth quarter. Oliver Luxxe Assets LLC now owns 13,470 shares of the company’s stock valued at $3,461,000 after acquiring an additional 51 shares in the last quarter. Finally, Glassman Wealth Services increased its holdings in HCA Healthcare by 28.7% in the second quarter. Glassman Wealth Services now owns 233 shares of the company’s stock valued at $39,000 after buying an additional 52 shares during the last quarter. 65.75% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Company Profile

(Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Stories

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.